Inventor
VENKAT R. THALLADI
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds24%
C07BGeneral methods of organic chemistry15%
C30BSingle-crystal growth3%
PatentTitleYear
12,351,561Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof202511,795,180Formulation of a pan-JAK inhibitor202311,780,852Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile202311,718,591Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof202311,718,616JAK kinase inhibitor compounds for treatment of respiratory disease202311,642,332(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid202311,452,723Combination dosage form of a mu opioid receptor antagonist and an opioid agent202211,230,536Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof202211,160,810Fused imidazo-piperidine JAK inhibitor compound202111,160,800Methods of treatment using a JAK inhibitor compound2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to THERAVANCE BIOPHARMA R&D IP LLC (10)· patent assignee history
2021Patents assigned to THERAVANCE BIOPHARMA R & D IP LLC (1)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| THERAVANCE BIOPHARMA R&D IP LLC | 10 | 2021–2025 |
| THERAVANCE BIOPHARMA R & D IP LLC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2021–2025 |